Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2023.28.21.2300116

PubMed Identifier: 37227299

Publication URI: http://europepmc.org/abstract/MED/37227299

Type: Journal Article/Review

Volume: 28

Parent Publication: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Issue: 21

ISSN: 1025-496X